Related Experiment Videos

[Substitution with blood coagulation factor XIII concentrates in patients with acute leukemia]

Beitrage Zu Infusionstherapie Und Klinische Ernahrung

|January 1, 1986

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia.

Leukemia·2016

Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia.

Annals of hematology·2002

Remission induction therapy: the more intensive the better?

Cancer chemotherapy and pharmacology·2001

Acute myeloid leukemia in adults: is postconsolidation maintenance therapy necessary?

International journal of hematology·2001

Differential inhibition of thrombin activity and thrombin generation by a synthetic direct thrombin inhibitor (napsagatran, Ro 46-6240) and unfractionated heparin in patients with deep vein thrombosis. ADVENT Investigators.

Thrombosis and haemostasis·1999

An exploratory trial of two dosages of a novel synthetic thrombin inhibitor (napsagatran, Ro 46-6240) compared with unfractionated heparin for treatment of proximal deep-vein thrombosis -- results of the European multicenter ADVENT trial.

Thrombosis and haemostasis·1997

See all related articles